Sunday, May 5th, 2013
Q1 2013 Drug Sales Data Released: Rough U.S Flu Season Boosts Numbers for Tamiflu
The latest U.S. drug sales data has been released by Drugs.com. The top five drugs have minor shifts in rank but exhibit positive growth for Q1 2013. Abilify, Otsuka’s second generation antipsychotic, and Nexium, AstraZeneca’s leading acid blocker, rank as the top two drugs by sales for the fourth quarter in a row. Both agents [...]
